Safety and Efficacy of Beclomethasone Dipropionate in Participants 4-11 Years Old With Persistent Asthma

Study Title

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma

Teva Identifier

BDB-AS-302 | 2013-004632-30

ClinicalTrials.gov Identifier

NCT02040766

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Beclomethasone dipropionate BAI | Drug: Placebo BAI | Drug: albuterol/salbutamol 90 mcg | Drug: Beclomethasone dipropionate MDI | Drug: Placebo MDI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations

Key Participation Requirements

Gender

Female, Male

Age Range

4 Years to 11 Years

Trial Duration

12/01/2013 - 03/01/2016

Phase

Phase 3

Study Type

Interventional